Predictors of smoking cessation: A longitudinal study in a large cohort of smokers

Holm, Mathias; Schiöler, Linus; Andersson, Eva; Forsberg, Bertil; Gíslason, Þórarinn; Janson, Christer; Jõgi, Rain; Schlünssen, Vivi; Svanes, Cecilie; Torén, Kjell

doi:10.1016/j.rmed.2017.10.013

Cited by 68 publications

(71 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our analysis also showed that higher education and household income are associated with quitting, which aligns with previous research [ 33 , 34 , 35 ]. In addition, our findings concerning lighter smoking and low levels of perceived addiction among those who quit [ 36 , 37 , 38 ] as well as the presence of a disease [ 10 , 27 , 39 ] or health concerns about smoking [ 10 , 40 , 41 ] are consistent with the literature.…”

Section: Discussionsupporting

confidence: 92%

Perceptions, Predictors of and Motivation for Quitting among Smokers from Six European Countries from 2016 to 2018: Findings from EUREST-PLUS ITC Europe Surveys

Girvalaki

Filippidis

Kyriakos

et al. 2020

IJERPH

View full text Add to dashboard Cite

The European Tobacco Products Directive (TPD) was introduced in 2016 in an effort to decrease prevalence of smoking and increase cessation in the European Union (EU). This study aimed to explore quitting behaviours, motivation, reasons and perceptions about quitting, as well as predictors (reported before the TPD implementation) associated with post-TPD quit status. A cohort study was conducted involving adult smokers from six EU countries (n = 3195). Data collection occurred pre-(Wave 1; 2016) and post-(Wave 2; 2018) TPD implementation. Bivariate and logistic regression analyses of weighted data were conducted. Within this cohort sample, 415 (13.0%) respondents reported quitting at Wave 2. Predictors of quitting were moderate or high education, fewer cigarettes smoked per day at baseline, a past quit attempt, lower level of perceived addiction, plans for quitting and the presence of a smoking-related comorbidity. Health concerns, price of cigarettes and being a good example for children were among the most important reasons that predicted being a quitter at Wave 2. Our findings show that the factors influencing decisions about quitting may be shared among European countries. European policy and the revised version of TPD could emphasise these factors through health warnings and/or campaigns and other policies.

show abstract

Section: Discussionsupporting

confidence: 92%

Perceptions, Predictors of and Motivation for Quitting among Smokers from Six European Countries from 2016 to 2018: Findings from EUREST-PLUS ITC Europe Surveys

Girvalaki

Filippidis

Kyriakos

et al. 2020

IJERPH

View full text Add to dashboard Cite

show abstract

“…After screening all included adjusted studies, nine studies were included in the meta-analyses for quit attempts (14, 19, 29, 31, 34-36, 41, 46) and 12 studies for abstinence (23,24,27,41,47,49,56,57,59,62,64,66). Results from ve studies ( Figure 18-1) were pooled to measure the association of menthol use and past year quit attempts.…”

Section: Results Of Meta-analysismentioning

confidence: 99%

“…The authors also acknowledge Thera-Business (Ontario CANADA) for providing their systematic review expertise to all study activities across all levels of the updated review process. Longest period of abstinence among current smokers (13), (14), (15), (16) Duration of most recent quit attempt among current smokers (15) Percent reporting longest quit time longer than 90 days among current smokers (17) Quit within past year vs. at least 1 year among former smokers (18) Quit between 3 months and 1 year; quit between 3 months and 5 years among former smokers (19) Time since quit (continuous measure) among former smokers (20), 21 (27) Tried to quit smoking in the past 12 months (28), (29), (30), (31), (32) At least 24 hours without smoking in the past 12 months because [respondent was] trying to quit smoking (25), (33), (34), (19), (35), (14), (12), (36) At least 24 hours without smoking ever because [respondent was] trying to quit smoking (14), (37) Intentionally abstained for at least 24 hours in the past 3 months (38), (39) At least 24 hours without smoking in the past 6 months (37) Any attempts (unde ned) to quit smoking [since previous interview] (40), 4124-hour abstinence (42) Use of a cessation program or aid (43), (27), (26), (32), (44) Other or de nition not reported (number of quit attempts) (45), (17),…”

Section: Acknowledgementsmentioning

confidence: 99%

“…Not smoking at all in past 6 months (46), (52), (50) Not smoking at all in the past 3 months (29), (30) Not purchasing a pack in past year (53) Former smoker vs. current smoker (54), (55) Ever-smokers identifying as "non-smoker" or smoking "not at all" or "not currently" at interview/survey (18), (56), (57), (58), (22), (59), (41) Quit ratio: number of former smokers / number of current plus number of former smokers (32) Not smoking ≥1 CPD in past year (55) Abstinence over the past 5 years with mean smoking ≤1 CPD (60) Transition from non-established smoking to non-smoking (61) 7-day PPA (62), (45), (27), (63), (26), (64), (65), (47), (23), (24), (66), (48), (49) 30-day PPA…”

Section: Acknowledgementsmentioning

confidence: 99%

“…Individual meta-analysis results from four cohort studies measuring the association of menthol use and smoking abstinence measured by 7-day PPA are presented inFigure 18-9. When pooling results across these four studies, Black menthol smokers had statistically signi cantly lower odds of smoking abstinence 7-day PPA (OR=0.52, 95% CI: 0.38 to 0.70, p<0.0001, I 2 =0%) (Figure 18-10)(24,27,47,49).…”

mentioning

confidence: 97%

See 2 more Smart Citations

Assessing the evidence on the differential impact of menthol versus non-menthol cigarette use on smoking cessation: A systematic review

Kim¹,

Curtin²

2020

Preprint

View full text Add to dashboard Cite

Background: This systematic review followed PRISMA guidelines to examine the Key Question: Does menthol cigarette use have a differential impact on smoking cessation compared with non-menthol cigarette use?Methods: The original protocol was registered on March 22, 2016 (updated January 10, 2019; PROSPERO: CRD42019119301). Six databases were queried from inception to December 14, 2018.Results: Fifty-seven studies (27 rated “good”, 27 rated as “fair”, and three studies rated as “poor” individual study quality) that compared menthol and non-menthol smokers were qualitatively synthesized across the following cessation measures (total adjusted studies; strength of evidence grade): duration of abstinence (2; low); quit attempts (14; insufficient); rate of abstinence/quitting (28; moderate); change in smoking quantity/frequency (3; insufficient); and return to smoking/relapse (2; insufficient). Overall, the qualitative synthesis failed to show a consistent trend for the association of menthol cigarette use and smoking cessation across the outcomes. Further, meta-analytic results found no difference between menthol and non-menthol cigarette use and the two measures of quit attempts and duration of abstinence.Implications: The overall strength of evidence for an association between menthol cigarette use and smoking cessation was graded as “low”, based on deficiencies of indirectness and inconsistency in the available body of evidence. Therefore, there is no consistent, significant, or differential association between menthol cigarette use and smoking cessation.

show abstract

Predictors of Smoking Cessation in Patients With Rheumatoid Arthritis in Two Cohorts: Most Predictive Health Care Factors

Schletzbaum

Wang

Greenlee

et al. 2021

Arthritis Care & Research

View full text Add to dashboard Cite

Objective Recognizing smoking as a risk factor for rheumatoid arthritis (RA) severity, the present study was undertaken to evaluate patient‐ and health care–level predictors of smoking cessation in patients with RA to guide implementation of smoking cessation interventions. Methods Electronic health record data from 2 health systems were abstracted for patients with at least 2 International Classification of Disease diagnosis codes for RA between 2005 and 2016. Patients missing smoking statuses or with <6 months of follow‐up were excluded. Multivariable logistic regression was used to determine predictors of smoking cessation. Results Among 3,577 patients with RA, 507 smoked at baseline, and 29% quit over a median of 4.75 years. Black male patients, ages 40–59 years and enrolled in Medicaid, were significantly more likely to be baseline smokers; however, none of these factors predicted cessation. Instead, patients new to rheumatology care were 60% more likely to quit (adjusted odds ratio [ORadj] 1.60 [95% confidence interval (95% CI) 1.02–2.50]), and patients in the rural community health system were 66% more likely to quit (ORadj 1.66 [95% CI 1.03–2.69]). Seropositive patients were 43% less likely to quit smoking (ORadj 0.57 [95% CI 0.35–0.91]). Conclusion Health care factors, including health system and being new to rheumatology care, were more predictive of smoking cessation in patients with RA than patient sociodemographic factors, suggesting an important role for health system cessation efforts for patients with RA. Seropositive patients were less likely to quit and may particularly benefit from cessation support. Emphasizing smoking cessation with new or seropositive RA patients and leveraging health system interventions could improve smoking cessation and outcomes in RA.

show abstract

Predictors of smoking cessation: A longitudinal study in a large cohort of smokers

Cited by 68 publications

References 34 publications

Perceptions, Predictors of and Motivation for Quitting among Smokers from Six European Countries from 2016 to 2018: Findings from EUREST-PLUS ITC Europe Surveys

Perceptions, Predictors of and Motivation for Quitting among Smokers from Six European Countries from 2016 to 2018: Findings from EUREST-PLUS ITC Europe Surveys

Assessing the evidence on the differential impact of menthol versus non-menthol cigarette use on smoking cessation: A systematic review

Predictors of Smoking Cessation in Patients With Rheumatoid Arthritis in Two Cohorts: Most Predictive Health Care Factors

Contact Info

Product

Resources

About